78 FOURTH AVENUE, WALTHAM, MA
Announces Pricing of $5.9 Million Registered Direct Offering
Announces Appointment of Joseph Doherty as Chairman of The Board
Changes in Board, Management or Compensation
Transforming Surgery: Open - like Access, Minimally Invasive
Earnings Release
Announces Leadership Transition: Stephen From, Healthcare Industry Veteran, Appointed Chief Executive Officer
News, Letter Re Change in Certifying Accountant
Announces Election of New Directors
Q2
Q1
FY 2024
Q3
Q1 amended
FY 2023
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence
Submission Upload
Post-Effective Amendment to Registration Statement
Registration Statement for Additional Securities, Filed Pursuant to Rule 462(b)